Delivery Order SPE2DB22D3301-SPE2DB24FX8AW

Award Date 1/3/24
Potential Completion Date 1/4/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 500 tablets of bupropion hydrochloride extended-release 150 mg. The delivery order is a firm fixed price contract with a potential value of $4,057.32 and a completion date of January 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that provides a range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,527.14 firm fixed price delivery order is for the supply of 500 tablets of Bupropion HCL XL 300 mg, a generic pharmaceutical product. This delivery order was not set aside for any specific business type. Amerisourcebergen Drug Corp has an established track record of providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $6,703.32 firm fixed price delivery order contract is for the supply of bupropion hydrochloride extended-release 150 mg tablets in 500-count bottles. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of Bupropion HCL XL 150 mg tablets. The award has a ceiling value of $50,053.26 and an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp, through its Corporate...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 500 tablets of Bupropion Hydrochloride Extended Release 300 mg. The $2,072.80 contract has a completion date of January 18, 2024. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contracts to supply pharmaceuticals and medical supplies to DLA Troop Support Medical...
Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $17,760 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 100 tablets of 100 milligram bupropion hydrochloride. The single day contract has a period of performance from September 21 through September 22, 2023, with all work taking place in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery...
The Defense Logistics Agency awarded a $26,640 delivery order to Amerisourcebergen Drug Corporation for 100-count bottles of 100mg bupropion hydrochloride tablets. The firm fixed price order is for product delivery to a facility in Conshohocken, Pennsylvania by September 1, 2023 in support of DLA pharmaceutical procurement programs. Amerisourcebergen will serve as the prime contractor, with performance taking place at its corporate headquarters. No subcontractors or set aside designations were...
Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp under a firm fixed price contract for the supply of 500 bupropion HCL XL 150 mg tablets. The one hundred three dollar order is for product delivery to a location in Conshohocken, Pennsylvania by September 25, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. No set-aside designation was applied to this order to fulfill pharmaceutical needs...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $96,000 firm fixed price delivery order by the Defense Logistics Agency to supply 4562127166 Bupropion HCl SR 100 mg tablets, 60 count, to a location in Conshohocken, Pennsylvania. The single day delivery order was issued under an existing DLA contract vehicle and funds research, development, testing, and evaluation programs of the Department of Defense. No set-aside designation or...
The Defense Logistics Agency awarded a $29,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561536610 Bupropion HCL SR 150 mg tablets, 60 count. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by July 19, 2023 in support of the Defense Logistics Agency's pharmaceutical procurement programs. Amerisourcebergen will serve as the prime contractor, with performance taking place at its corporate office division. No...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX8AW
    Delivery Order

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The $14,133.14 award is for the delivery of bupropion hydrochloride extended-release 150 mg tablets to support DLA Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp has a track record of providing pharmaceuticals and medical supplies to DLA under various contracts. This order does not have a set-aside designation and is scheduled for completion by January 4, 2024. Amerisourcebergen Drug Corp's Corporate Office division in Conshohocken, Pennsylvania will be the place of performance.

Generated 4/3/24, 10:36 AM